Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00200109 · ClinicalTrials.gov registry record · Phase 1
Occipital Nerve Stimulation for the Treatment of Chronic Migraine Headache.
A Phase 1 study of Chronic Migraine, Headache, sponsored by MedtronicNeuro.
- Completed
- Registry status
- Phase 1
- Development phase
- 110
- Enrollment target
- 9
- Study locations
NCT00200109: Completed Phase 1 study of Chronic Migraine, Headache, sponsored by MedtronicNeuro.
NCT00200109 is a Phase 1 study of Chronic Migraine, Headache that has completed, run by MedtronicNeuro. The registered enrollment target is 110 participants, below the 230-participant average among 4 other Chronic Migraine, Headache trials with a reported enrollment target (52% lower). The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00200109, a Phase 1 study of Chronic Migraine, Headache, has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 110 participants
- Enrollment target
- 9
- Study locations
Study Summary
Background: Medically intractable chronic migraine (CM) is a disabling illness characterized by headache greater than 15 days per month. Method: A multicenter, randomized, blinded, controlled feasibility study was conducted to obtain preliminary safety and efficacy data on occipital nerve stimulation (ONS) in CM. Eligible subjects received an occipital nerve block, and responsers were randomized to adjustable stimulation (AS), preset stimulation (PS) or medical management (MM) groups.
Conditions Studied
Interventions
- DEVICE Occipital Nerve Stimulation
Study Locations (9)
Michigan
- Contact Medtronic for Exact Locations - Ann Arbor
- Contact Medtronic for Exact Locations - Detroit
Arizona
- Contact Medtronic for Exact Location - Scottsdale
California
- Contact Medtronic for Exact Locations - Oceanside
Colorado
- Contact Medtronic for Exact Locations - Denver
Oklahoma
- Contact Medtronic for Exact Locations - Oklahoma City
Pennsylvania
- Contact Medtronic for Exact Locations - Philadelphia
Alberta
- Contact Medtronic for Exact Location - Calgary
Other
- Contact Medtronic for Exact Location - London
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2004-05 |
| Est. Completion | 2011-05 |
| Phase | Phase 1 |
What the finished NCT00200109 record still lists
NCT00200109 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 230-participant average among 4 other Chronic Migraine, Headache trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Chronic Migraine, Headache appearing as the primary indexed condition, and to 1 intervention - of which Occipital Nerve Stimulation is the first listed.
NCT00200109 lists 9 locations in 8 states (Michigan, Arizona, California).
Frequently Asked Questions
What is clinical trial NCT00200109 about?
NCT00200109 is a clinical study titled "Occipital Nerve Stimulation for the Treatment of Chronic Migraine Headache.". Background: Medically intractable chronic migraine (CM) is a disabling illness characterized by headache greater than 15 days per month. Method: A multicenter, randomized, blinded, controlled feasibility study was conducted to obtain preliminary safety and efficacy data on occipital nerve stimulati...
What is the current status of trial NCT00200109?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 110 participants. The study started on 2004-05. Estimated completion is 2011-05.
What conditions does trial NCT00200109 study?
This clinical trial studies the following conditions: Chronic Migraine, Headache.
What interventions are being tested in trial NCT00200109?
The interventions under investigation include: Occipital Nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT00200109?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00200109 being conducted?
This trial has 9 study locations across Arizona, California, Colorado, Michigan, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Migraine, Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
RECRUITING
-
Open Label, 6-month Study for High Frequency and Chronic Migraine,
ACTIVE NOT RECRUITING
-
COACT Study: CGRPmAbs + OnabotulinumtoxinA Assessment of Chronic Migraine Treatments Study
ACTIVE NOT RECRUITING · Phase 4
-
Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia